Support of sufficient funding for the Food & Drug Administration to conduct meaningful and effective review of Direct-to-Consumer advertising S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage
Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage
S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs
Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement
340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate
General discussion and increasing awareness of patient assistance program offerings
Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and MedicareAdvantage S.1145, The Patent Reform Act of 2007, Potenital implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries
Intellectual property provisions of Free-Trade Agreements and otherwise as part of US trade policy HR 1432, HR 1902 - Patent Settlement Bills re: prohibition of brand name manufacturers compensating generic manufacturers for delay of generic entry to market
HR 5629, Pathway for Biosimilars Act, U.S. House - legislation regarding patent protection of biological products re: generic/follow-on biologic products No specific legislation, but discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment
Illegal compounding of commercially available pharmaceuticals by pharmacists
Patient safety from the commercial importation of prescription medications Legislative proposals regarding potential implementation of drug "pedigree" mechanism to monitor flow of pharmaceuticals from manufacturer to consumer
PHA - Pharmacy HCR - Health Issues MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark CSP - Consumer Issues/Safety/Products
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 12 - White House Office
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
WAYNE PALMER RICHARD BUCKLEY MICHAEL DRAINE ANDRES IZQUIERDO AMANDA GRASHOF MOTT RICHARD WAYNE OLSON WAYNE PALMER BRADLEY ALLEN ROSSIN KENNETH LEVINSON (Leg. Assistant to Sen. Jay Rockefeller 1991-97) RICHARD BUCKLEY ANDRES IZQUIERDO AMANDA GRASHOF MOTT RICHARD WAYNE OLSON WAYNE PALMER BRADLEY ALLEN ROSSIN RICHARD BUCKLEY KENNETH LEVINSON (Leg. Assistant to Sen. Jay Rockefeller 1991-97) AMANDA GRASHOF MOTT BRADLEY ALLEN ROSSIN MICHAEL DRAINE BRADLEY ALLEN ROSSIN
Leg. Assistant to Sen. Jay Rockefeller 1991-97 Leg. Assistant to Sen. Jay Rockefeller 1991-97